Genomic Analysis_990x120
watch on demand (2)
If you have already registered, follow this link and enter your e-mail address into the "Already Registered?" field to view the webinar.

Event Overview

Genotyping during the active study phase of clinical trials is becoming more popular because of lower costs and the availability of high-throughput microarray platforms that quickly provide accurate results. During oncology clinical trials, genomics data enable better patient stratification, optimized study results, and well-planned study designs. In this webinar brought to you by The Scientist, our panel of experts will discuss the current state and future direction of genomic analysis in oncology clinical trials.

Topics to be Covered

  • Pros and cons of biomarker based patient selection versus biomarker discovery in clinical trials
  • Breast cancer precision medicine: the right drug for the right patient at the right time
Friday, October 25, 2019
 
2:30 - 4:00 PM Eastern Time


Speakers

Pusktai 100x100.png
Lajos Pusztai, MD, DPhil
Professor of Medicine (Medical Oncology)
Breast Medical Oncology Group
Yale School of Medicine

Vant Veet.png
Laura J. van 't Veer, PhD
Leader, Breast Oncology Program
Director, Applied Genomics
UCSF Helen Diller Family Comprehensive Cancer Center
Angela and Shu Kai Chan Endowed Chair in Cancer Research


Brooks Logobox.png

Register Now

Genomic Analysis: Steering Clinical Trials

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with Brooks Life Sciences, the sponsoring vendor of this webinar. Our sponsors may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.